North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as…
North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixent. The post North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug appeared first…
How a Cancer Diagnosis Shaped This VC’s Precision Health Thesis
After a near-miss with her own breast cancer diagnosis, Ariel Ganz co-founded Arben Ventures, a precision health and longevity fund that has backed 83 early-stage startups in three years. The post How a Cancer Diagnosis Shaped This VC’s Precision Health Thesis appeared first on MedCity News.
UC San Diego Researchers Study Physician Edits to AI-Drafted Messages
In NEJM AI paper, researchers say understanding where and why physicians modify AI-generated content is a first step to realizing their value
The Missing Link in Surgical Safety: Integrating Patient Warming and Positioning
Historically, warming and positioning have been addressed independently because, in many surgical procedures, they do not significantly interfere with one another. However, that’s not the case in most robotic-assisted surgeries. The post The Missing Link in Surgical Safety: Integrating Patient Warming and Positioning appeared first on MedCity News.
3 Common Drugs Older Adults Might Be Overusing
The scenario often unfolds like this: Medical researchers investigate a frequently used drug and report that it’s less effective for older patients than previously thought, or that its risks outweigh its benefits in older adults. More studies follow, confirming those findings. After a few years, medical associations revise their guidelines, warning that the drug in…
California Eyes Prison Heat Protections That Fall Short of Workplace Standards
As Californians have weathered relentless heat waves, state workplace safety regulators have repeatedly reminded employers to protect employees from heat illness by providing water, shade, cooldown areas, and additional rest breaks when temperatures climb. But there’s a notable exception in the state’s heat safety rules: Not covered are the nurses, guards, staff, and tens of…
Gozio – Patient Navigation & Directions!
I had a great conversation and demo with Katie Logan and Christine Smith from Gozio a while back. Finally got it up on THCB. Gozio provides two types of patient navigation for health systems. One as a digital front door helping patients navigate to doctors, services and tools like virtual care and appointments from the…
Start Counting Your Days
By KIM BELLARD Probably the last thing the world needs is to hear from me about AI’s existential threat, but, really, what else is there to talk about right now? For anyone who has not been following the current furor, the straw that broke the proverbial camel’s back came last week when Jacob Coxon, a…
Tech Check: Tenet and HCA CEOs Talk AI at Wells Conference
Saum Sutaria discussed the costs of payment adjudications while Sam Hazen detailed his team’s “holy grail” when it comes to the technology.
Novartis Gains a Way to Get Drugs Into the Brain, Buying Sironax Tech for $125M
Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective blood-brain barrier. The deal comes as Novartis weathers several pipeline setbacks, including trial failures for neuroscience drug candidates. The post Novartis Gains a Way to Get Drugs Into the Brain, Buying Sironax Tech for $125M appeared first…
